Two rare genetic eye disorders, known as Retinitis Pigmentosa (RP) and Stargardt Disease (STGD), both falling under the classification of Inherited Retinal Diseases (IRDs), have emerged as focal points of investigation in the pursuit of potential treatments leveraging cutting-edge technologies, notably artificial intelligence (AI) integrated with fundoscopy. These IRDs, characterized by their genetic underpinnings, serve as poignant reminders of the intricate and multifaceted nature of genetic eye disorders. The primary objective of this work was to develope an algorithm capable of automatically categorizing fundoscopies obtained from 74 pediatric eyes. In pursuit of this goal, an artificial intelligence algorithm was developed, exploiting the YOLOv8n Net. Through rigorous testing, it was demonstrated that this algorithm effectively and accurately classified the samples within the test set, exhibiting a notable absence of misclassification errors. The overarching ambition of this study is to introduce a robust and reliable classification tool that can significantly enhance the diagnostic process for rare diseases such as RP and STGD. By leveraging the power of advanced technologies, particularly AI, this research endeavors to streamline and optimize diagnostic procedures, thereby offering hope for improved management and treatment outcomes for individuals affected by these challenging conditions.

Rare Eye Diseases Automatic Classification: A Deep Learning Approach

Vitale Jacopo;Matarrese Margherita Anna Grazia;Pecchia Leandro
2024-01-01

Abstract

Two rare genetic eye disorders, known as Retinitis Pigmentosa (RP) and Stargardt Disease (STGD), both falling under the classification of Inherited Retinal Diseases (IRDs), have emerged as focal points of investigation in the pursuit of potential treatments leveraging cutting-edge technologies, notably artificial intelligence (AI) integrated with fundoscopy. These IRDs, characterized by their genetic underpinnings, serve as poignant reminders of the intricate and multifaceted nature of genetic eye disorders. The primary objective of this work was to develope an algorithm capable of automatically categorizing fundoscopies obtained from 74 pediatric eyes. In pursuit of this goal, an artificial intelligence algorithm was developed, exploiting the YOLOv8n Net. Through rigorous testing, it was demonstrated that this algorithm effectively and accurately classified the samples within the test set, exhibiting a notable absence of misclassification errors. The overarching ambition of this study is to introduce a robust and reliable classification tool that can significantly enhance the diagnostic process for rare diseases such as RP and STGD. By leveraging the power of advanced technologies, particularly AI, this research endeavors to streamline and optimize diagnostic procedures, thereby offering hope for improved management and treatment outcomes for individuals affected by these challenging conditions.
2024
9783031616273
9783031616280
Two rare genetic eye disorders, known as Retinitis Pigmentosa (RP) and Stargardt Disease (STGD), both falling under the classification of Inherited Retinal Diseases (IRDs), have emerged as focal points of investigation in the pursuit of potential treatments leveraging cutting-edge technologies, notably artificial intelligence (AI) integrated with fundoscopy. These IRDs, characterized by their genetic underpinnings, serve as poignant reminders of the intricate and multifaceted nature of genetic eye disorders. The primary objective of this work was to develope an algorithm capable of automatically categorizing fundoscopies obtained from 74 pediatric eyes. In pursuit of this goal, an artificial intelligence algorithm was developed, exploiting the YOLOv8n Net. Through rigorous testing, it was demonstrated that this algorithm effectively and accurately classified the samples within the test set, exhibiting a notable absence of misclassification errors. The overarching ambition of this study is to introduce a robust and reliable classification tool that can significantly enhance the diagnostic process for rare diseases such as RP and STGD. By leveraging the power of advanced technologies, particularly AI, this research endeavors to streamline and optimize diagnostic procedures, thereby offering hope for improved management and treatment outcomes for individuals affected by these challenging conditions.
File in questo prodotto:
File Dimensione Formato  
12_2024Vitale.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 2.63 MB
Formato Adobe PDF
2.63 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12610/78685
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact